Optimizing Red Light-Based Photodynamic Therapy for Effective Bactericidal Action Against Fusobacterium nucleatum Subspecies
Year: 2024
Type: article
Abstract: Fusobacterium nucleatum (F. nucleatum), a key pathogen implicated in periodontal disease, contributes to oral biofilm maturation and is linked to development of systemic diseases like colorectal cancer and liver cirrhosis. Photodynamic therapy (PDT) combined with 5-aminolevulinic acid (5-ALA) treatment (ALA-PDT) selectively targets F. nucleatum by inducing porphyrin accumulation. The bactericidal effect of red light-based PDT on F. nucleatum has not been evaluated previously. This study investigates the effect of ALA-PDT using red light-emitting diode (LED) light on F. nucleatum subspecies and their porphyrin accumulation. F. nucleatum subspecies were cultured with varying concentrations of 5-ALA under anaerobic conditions. Porphyrin accumulation was measured via fluorescence spectroscopy, and colony-forming units were measured to determine bacterial viability post-treatment. Additionally, other subspecies responded well to 0.01% 5-ALA, and uroporphyrin I accumulation correlated with bacterial death, revealing optimal bactericidal conditions. These results suggest that optimizing light intensity and 5-ALA concentration can significantly enhance the therapeutic potential of ALA-PDT in oral healthcare.
Source: Pathogens
Institutions: Osaka Dental University, Southern Medical University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,069
Awards: 硝酸塩(NO3-)をプレバイオティックスとして用いた新規健康増進アプローチの開発, Development of oral health evaluation method using resilience of oral microbiota as an index, プレバイオティクスを見据えた細菌叢と免疫細胞の偏移に関わる物質探索, Construction of a novel oral health indicator based on an oral microbiota culture model, Development of a safe method to control the oral microbiota that varies among individuals, Selective neutralization of Fusobacterium nucleatum using chicken egg antibodies and development of an oral microbiota transition method
OpenAlex ID: W4404527975
